View Item 

Show simple item record

A Phase 2 study of cisplatin analog CI-973 in the treatment of patients with refractory, advanced ovarian cancer

dc.contributor.authorRoberts, James A.en_US
dc.contributor.authorKudelka, A. P.en_US
dc.contributor.authorSpriggs, D. R.en_US
dc.contributor.authorMuggia, F.en_US
dc.contributor.authorLurain, J.en_US
dc.contributor.authorGrove, W.en_US
dc.contributor.authorKowal, C.en_US
dc.date.accessioned2010-06-01T18:22:57Z
dc.date.available2010-06-01T18:22:57Z
dc.date.issued1996-07en_US
dc.identifier.citationRoberts, J.A.; Kudelka, A.P.; Spriggs, D.R.; Muggia, F.; Lurain, J.; Grove, W.; Kowal, C. (1996). "A Phase 2 study of cisplatin analog CI-973 in the treatment of patients with refractory, advanced ovarian cancer." International Journal of Gynecological Cancer 6(4): 257-260. <http://hdl.handle.net/2027.42/71591>en_US
dc.identifier.issn1048-891Xen_US
dc.identifier.issn1525-1438en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71591
dc.format.extent397866 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Inc.en_US
dc.rightsInternational Gynecologic Cancer Societyen_US
dc.subject.otherCI-973en_US
dc.subject.otherOvarian Canceren_US
dc.subject.otherPhase 2 Studyen_US
dc.subject.otherPlatinum Analogen_US
dc.titleA Phase 2 study of cisplatin analog CI-973 in the treatment of patients with refractory, advanced ovarian canceren_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelObstetrics and Gynecologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationum* Division of Gynecologic Oncology, University of Michigan, Ann Arbor, Michigan,en_US
dc.contributor.affiliationum** Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationotherSection of Gynecologic Medical Oncology, M.D. Anderson Cancer Center, Houston, Texas,en_US
dc.contributor.affiliationotherDepartment of Human Oncology, University of Wisconsin, Madison, Wisconsin,en_US
dc.contributor.affiliationotherKenneth Norris Comprehensive Cancer Center, University of Southern California, Los Angeles,en_US
dc.contributor.affiliationotherSection of Gynecologic Oncology, Northwestern University Medical School, Chicago, Illinois anden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71591/1/j.1525-1438.1996.06040257.x.pdf
dc.identifier.doi10.1046/j.1525-1438.1996.06040257.xen_US
dc.identifier.sourceInternational Journal of Gynecological Canceren_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1525-1438.1996.06040257.x.pdf
Size:
388.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.